Core Laboratories
CLB
162 hedge funds and large institutions have $615M invested in Core Laboratories in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 50 reducing their positions, and 30 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 50
0.3% less ownership
Funds ownership: 98.64% → 98.34% (-0.3%)
8% less funds holding
Funds holding: 176 → 162 (-14)
32% less capital invested
Capital invested by funds: $905M → $615M (-$290M)
38% less call options, than puts
Call options by funds: $641K | Put options by funds: $1.03M
40% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$9.79M |
| 2 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
+$3.44M |
| 3 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$3.25M |
| 4 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$2.95M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
-$11.5M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$3.38M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$2.87M |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$1.92M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.69M |
CLB Hedge Fund Activity: Q3 2022 in Review
162 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2022, worth a combined $615M — down 32% from $905M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CLB and 18 opened new positions — a net loss of 12 holders — while 50 trimmed existing stakes and 70 added.
The largest buyer was Ariel Investments, adding an estimated $9.79M. The largest seller was VanEck Associates, cutting an estimated $11.5M.
- 162 institutional investors held Core Laboratories (CLB) as of Q3 2022, down from 176 in Q2 2022.
- Funds reported $615M of Core Laboratories stock for Q3 2022, down 32% quarter-over-quarter.
- 18 funds opened new Core Laboratories positions in Q3 2022 and 30 closed out, a net change of -12 holders.
- The largest Core Laboratories buyer in Q3 2022 was Ariel Investments, an estimated $9.79M added.
- The largest Core Laboratories seller in Q3 2022 was VanEck Associates, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2022.